Cancer Letters
Volume 203, Issue 2 , Pages 209-215 , January 2004

Expression and regulation of tumor suppressor gene maspin in human bladder cancer

  • Shuji Sugimoto

      Affiliations

    • Department of Urology, University of Kiel, Arnold-Heller-strasse 7, Kiel 24105, Germany
    • ,
  • Nicolai Maass

      Affiliations

    • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kiel, Michaelisstrasse 16, Kiel 24105, Germany
    • ,
  • Yukie Takimoto

      Affiliations

    • Department of Urology, Nihon University, 30-1 Oyaguchikamimachi, Itabashi-ku, Tokyo 173-8610, Japan
    • ,
  • Katsuhiko Sato

      Affiliations

    • Department of Urology, Nihon University, 30-1 Oyaguchikamimachi, Itabashi-ku, Tokyo 173-8610, Japan
    • ,
  • Sadatsugu Minei

      Affiliations

    • Department of Urology, Nihon University, 30-1 Oyaguchikamimachi, Itabashi-ku, Tokyo 173-8610, Japan
    • ,
  • Ming Zhang

      Affiliations

    • Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    • ,
  • Yutaka Hoshikawa

      Affiliations

    • Department of Gene Expression, Genome Center, Japanese Foundation for Cancer Research, Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170-8455, Japan
    • ,
  • Klaus-Peter Jünemann

      Affiliations

    • Department of Urology, University of Kiel, Arnold-Heller-strasse 7, Kiel 24105, Germany
    • ,
  • Walter Jonat

      Affiliations

    • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kiel, Michaelisstrasse 16, Kiel 24105, Germany
    • ,
  • Koichi Nagasaki

      Affiliations

    • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kiel, Michaelisstrasse 16, Kiel 24105, Germany
    • Corresponding Author InformationCorresponding author. Address: Department of Gene Expression, Genome Center, Japanese Foundation for Cancer Research, Cancer Institute, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170-8455, Japan. Tel.: +81-3-5394-3906; fax: +81-3-5394-3926

Received 28 August 2003 ,Revised 1 September 2003 ,Accepted 2 September 2003.

References 

  1. Herr HW. Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome. J. Urol. 2000;163:60–62
  2. Reiher F, Ozer O, Pins M, Jovanovic BD, Eggener S, Campbell SC. p53 and microvessel density in primary resection specimens of superficial bladder cancer. J. Urol. 2002;167:1469–1474
  3. Yuge F, Hirakata H, Kodama M, Kawata N, Takimoto Y. Immunohistochemical study of p53 and Ki-67 antigen expression in bladder carcinoma. Hinyokika. Kiyo. 1999;45:453–456
  4. Gontero P, Tizzani A, Muir GH, Caldarera E, Macaluso MP. The genetic alterations in the oncogenic pathway of transitional cell carcinoma of the bladder and its prognostic value. Urol. Res. 2001;29:377–387
  5. Zou Z, Anisowicz A, Hendrix MJC, Thor A, Neveu M, Sheng S, et al.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science. 1994;263:526–529
  6. Maass N, Teffner M, Rösel F, Pawaresch R, Jonat W, Nagasaki K, et al. Decline in the expression of the serine proteinase inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J. Pathol. 2001;195:321–326
  7. Zou Z, Zhang W, Young D, Gleave MG, Rennie P, Connell T, et al.  Maspin expression profile in human prostate cancer (CaP) and in vitro induction of maspin expression by androgen ablation. Clin. Cancer Res. 2002;8:1172–1177
  8. Song SY, Lee SK, Kim DH, Son HJ, Kim HJ, Lim YJ, et al.  Expression of maspin in colon cancers its relationship with p53 expression and microvessel density. Dig. Dis. Sci. 2002;47:1831–1835
  9. Xia W, Lau Y, Hu MC-T, Li L, Johnston DA, Sheng S, et al.  High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene. 2000;19:2398–2403
  10. Umekita Y, Hiipakka RA, Liao S. Rat and human maspin: structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Lett. 1997;113:87–93
  11. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP. AJCC cancer staging manual. Philadelphia: Lippincott Raven; 1997;
  12. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urologic Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am. J. Surg. Pathol. 1998;22:1435–1438
  13. Maass N, Biallek M, Rösel F, Schem C, Ohike N, Zhang M, et al.  Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem. Biophys. Res. Commun. 2002;297:125–128
  14. Maass N, Hojo T, Rösel F, Ikeda T, Jonat W, Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin. Biochem. 2001;34:303–307
  15. Hemal AK, Khaitan A, Dinda AK, Gupta NP, Seth A, Dogra PN, et al. Prognostic significance of p53 nuclear overexpression in patients of muscle invasive urinary bladder carcinoma treated with cystectomy. Urol. Int. 2003;70:42–46
  16. Maass N, Hojo T, Ueding M, Lüettges J, Kloeppel G, Jonat W, et al. Expression of tumor suppressor gene maspin in human pancreatic cancers. Clin. Cancer Res. 2001;7:812–817
  17. Maass N, Nagasaki K, Teffner M, Mundhenke C, Jonat W. Expression and regulation of tumor suppressor gene maspin in breast cancer. Clin. Breast Cancer. 2002;3:281–287
  18. Futscher BW, Oshiro MM, Wozniak RJ, Holtan N, Hanigan CL, Duan H, et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat. Genet. 2002;31:175–179
  19. Colquhoun AJ, Jones GD, Moneef MA, Bowman KJ, Kockelbergh RC, Symods RP, et al.  Improving and predicting radiosensitivity in muscle invasive bladder cancer. J. Urol. 2003;169:1983–1992
  20. Son HJ, Sohn TS, Song SY, Lee JH, Rhee JC. Maspin expression in human gastric adenocarcinoma. Pathol. Int. 2002;52:508–513
  21. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, et al.  The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 2002;8:2924–2932
  22. Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, et al.  Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int. J. Cancer. 2001;95:337–342
  23. McShane LM, Aamodt R, Cordon-Cardo C, Cote R, Faraggi D, Fradet Y, et al.  The National Cancer Institute Bladder Tumor Marker Network, Reproducibility of p53 immunohistochemistry in bladder tumors. Clin. Cancer Res. 2000;6:1854–1864
  24. Tiguert R, Lessard A, So A, Fradet Y. Prognostic markers in muscle invasive bladder cancer. World J. Urol. 2002;20:190–195
  25. Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, et al.  p53 regulates the expression of the tumor suppressor gene maspin. J. Biol. Chem. 2000;275:6051–6054
  26. Zhang M, Maass N, Magit D, Sager R. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin. Cell Growth Differ. 1997;8:179–186

PII: S0304-3835(03)00587-1

doi: 10.1016/j.canlet.2003.09.010

Cancer Letters
Volume 203, Issue 2 , Pages 209-215 , January 2004

Article Tools

* Image Usage & Resolution